@article{ref1,
title="Antipsychotic dose reduction compared to dose continuation for people with schizophrenia",
journal="Cochrane database of systematic reviews",
year="2021",
author="Bighelli, I. and Samara, M.T. and Rodolico, A. and Hansen, W.-p. and Leucht, S.",
volume="2021",
number="4",
pages="-",
abstract="OBJECTIVES: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the effects and safety of reducing antipsychotic dose compared to continuing the dose for people with schizophrenia. To examine factors of dose reduction such as its degree and rapidity. Copyright © 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.<p /><p>Language: en</p>",
language="en",
issn="1465-1858",
doi="10.1002/14651858.CD014384",
url="http://dx.doi.org/10.1002/14651858.CD014384"
}